Everhart Financial Group’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$753K Sell
7,282
-900
-11% -$80.3K 0.05% 220
2026
Q1
$588K Sell
8,182
-868
-10% -$66.9K 0.05% 243
2025
Q4
$718K Buy
9,050
+2,128
+31% +$168K 0.07% 211
2025
Q3
$522K Buy
6,922
+1,435
+26% +$98.3K 0.05% 245
2025
Q2
$378K Buy
+5,487
New +$360K 0.04% 265
2024
Q2
Sell
-5,742
Closed -$458K 300
2024
Q1
$458K Buy
5,742
+2,260
+65% +$173K 0.13% 160
2023
Q4
$275K Sell
3,482
-138
-4% -$9.82K 0.1% 194
2023
Q3
$253K Buy
+3,620
New +$256K 0.11% 176
2022
Q4
Sell
-4,683
Closed -$446K 200
2022
Q3
$446K Buy
4,683
+561
+14% +$55.5K 0.25% 79
2022
Q2
$382K Buy
4,122
+1,235
+43% +$121K 0.23% 101
2022
Q1
$292K Buy
+2,887
New +$303K 0.17% 94

Other funds holding CVS

Everhart Financial Group's CVS Position: Q2 2026 in Review

Everhart Financial Group reduced its CVS Health (CVS) stake by 11% in Q2 2026, selling an estimated $80.3K and leaving 7,282 shares worth $753K. The position accounts for 0.05% of the portfolio, ranked #220.

Everhart Financial Group first reported a position in CVS in Q1 2022 and has held it in 11 quarters since. 459 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Everhart Financial Group held 7,282 shares of CVS Health worth $753K as of Q2 2026.
  • Everhart Financial Group sold 900 CVS Health shares in Q2 2026, an estimated $80.3K.
  • CVS Health made up 0.05% of Everhart Financial Group's portfolio in Q2 2026, its #220 holding.
  • Everhart Financial Group first reported a position in CVS Health in Q1 2022 and has held it in 11 quarters since.
  • 459 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.